Condition

Facial Injuries clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Facial Injuries clinical trials that are recruiting, at sites in 2 countries (most in United States (2), Yemen (1)). By phase: Phase 2 (1), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Facial Injuries clinical trials

StudyPhaseWhereStatusRegistered
Topical Dexa/Diclofenac Gel for Pain and Swelling After Facial Surgery Phase 2/3 Dhamar Recruiting Oct 2, 2026
Transplanting face and arm tissue to improve function and appearance — New York, New York Recruiting Aug 15, 2019
Face transplantation using bone marrow cell therapy and reduced immunosuppression Phase 2 Baltimore, Maryland Recruiting Jun 28, 2013

All recruiting trials (3)

Related topics

Hand Injuries

Quick answers

How many Facial Injuries clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United States (2 trials), Yemen (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.